Research studies seeking participants


The following studies are being conducted at sites in North Carolina by NCSG members. The conditions are listed in alphabetical order and currently include the list below.

January 31, 2022

Eosinophilic Esophagitis

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Etrasimod in Adult Subjects With Eosinophilic Esophagitis   Study title A Phase […]
January 31, 2022

Short Bowel Syndrome

VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome   Study title VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome Disease or condition Short bowel […]
January 31, 2022

Primary Biliary Cholangitis

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)   Study title Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) Disease or condition Primary Biliary Cholangitis Study type Interventional […]
January 31, 2022

Primary Sclerosing Cholangitis

A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis   Study title […]
January 31, 2022

Nonalcoholic Steatohepatitis (NASH)

A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH) (Harmony)   Study title A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically […]
January 31, 2022

Nonalcoholic Steatohepatitis (NASH)

A Phase 2b, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Saroglitazar Magnesium in Subjects with Nonalcoholic Steatohepatitis and Fibrosis   Study […]
September 10, 2021

Nonalcoholic Steatohepatitis (NASH)

A Phase 2b, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Saroglitazar Magnesium in Subjects with Nonalcoholic Steatohepatitis and Fibrosis   Study […]
May 31, 2021

Ulcerative Colitis

Study title Phase 1, Open Label, Drug Interaction Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in […]
May 31, 2021

Ulcerative Colitis

Study title A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis (QUASAR) Disease or condition Ulcerative colitis Study type Interventional  (Clinical Trial) […]